Darryl McConnell

Managing Director at Resonate Bio GmbH

Presenter

Darryl McConnell has 30 years of drug discovery experience and has thus far been involved in discovering 26 development stage compounds and 11 clinical stage drug candidates. Darryl is co-founder and Managing Director of the new Austrian startup Resonate Bio GmbH and also works at Curie Bio building early stage Biotech companies. Previously Darryl was Senior Vice President and Research Site Head at Boehringer-Ingelheim’s Oncology Research Center in Vienna. Darryl’s interests lie in drugging the most important "undruggable" drug targets with innovation and team science. Earlier in his scientific career, Darryl studied chemistry and worked in Biotech in Australia and is author of over 75 peer reviewed publications and patents.